{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:23:05Z","timestamp":1773206585389,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["321S185"],"award-info":[{"award-number":["321S185"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016209","name":"Erciyes University Scientific Research Projects Coordination Unit","doi-asserted-by":"publisher","award":["TDH-2022-11679"],"award-info":[{"award-number":["TDH-2022-11679"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijoms.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijom.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:35:33Z","timestamp":1758584133000},"page":"310-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enamel matrix derivative in the prevention and treatment of medication-related osteonecrosis of the jaws in rats"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3787-4564","authenticated-orcid":false,"given":"C.","family":"Eren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9868-6415","authenticated-orcid":false,"given":"C.Y.","family":"Asan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-8052","authenticated-orcid":false,"given":"C.","family":"Topan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Demirbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijom.2025.09.004_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the jaws\u20142022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2025.09.004_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","article-title":"Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw","volume":"12","author":"He","year":"2020","journal-title":"Int J Oral Sci"},{"issue":"5","key":"10.1016\/j.ijom.2025.09.004_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10050680","article-title":"Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic approaches","volume":"10","author":"On","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijom.2025.09.004_bib4","first-page":"212","article-title":"Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management","volume":"32","author":"Abdolrahmani","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijom.2025.09.004_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/jcpe.12546","article-title":"Twenty years of enamel matrix derivative: the past, the present and the future","volume":"43","author":"Miron","year":"2016","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.ijom.2025.09.004_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/jre.12245","article-title":"Enamel matrix derivative, inflammation and soft tissue wound healing","volume":"50","author":"Miron","year":"2015","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.ijom.2025.09.004_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1902\/jop.2010.100180","article-title":"Effects of enamel matrix derivative on vascular endothelial growth factor expression and microvessel density in gingival tissues of periodontal pocket: a comparative study","volume":"82","author":"Aspriello","year":"2011","journal-title":"J Periodontol"},{"key":"10.1016\/j.ijom.2025.09.004_bib8","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1007\/s00784-023-05254-1","article-title":"Effects of enamel matrix derivative in nonsurgical periodontal therapy on pro-inflammatory profiles, microbial environment and clinical outcome: a randomized clinical trial","volume":"27","author":"Wehner","year":"2023","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.ijom.2025.09.004_bib9","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/life14091088","article-title":"The potential of enamel matrix derivative in countering bisphosphonate-induced effects in osteoblasts","volume":"14","author":"Kim","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ijom.2025.09.004_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.oooo.2013.11.490","article-title":"Does an alkaline environment prevent the development of bisphosphonate-related osteonecrosis of the jaw? An experimental study in rats","volume":"117","author":"Dayisoylu","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ijom.2025.09.004_bib11","doi-asserted-by":"crossref","first-page":"20130144","DOI":"10.1259\/dmfr.20130144","article-title":"Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model","volume":"43","author":"Ersan","year":"2014","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.ijom.2025.09.004_bib12","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2025.09.004_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-9657.2005.00370.x","article-title":"Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. A pilot study","volume":"21","author":"Moreira","year":"2005","journal-title":"Dent Traumatol"},{"key":"10.1016\/j.ijom.2025.09.004_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ijom.2025.09.004_bib15","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.joms.2011.05.002","article-title":"Effects of pamidronate on human alveolar osteoblasts in vitro","volume":"70","author":"Marolt","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2025.09.004_bib16","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.joms.2011.03.005","article-title":"Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts","volume":"69","author":"Cozin","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2025.09.004_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/ten.teb.2011.0365","article-title":"Enamel matrix derivative: a review of cellular effects in vitro and a model of molecular arrangement and functioning","volume":"18","author":"Grandin","year":"2012","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.ijom.2025.09.004_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1034\/j.1600-0765.2003.00610.x","article-title":"Effect of Emdogain on human periodontal fibroblasts in an in vitro wound-healing model","volume":"38","author":"Rincon","year":"2003","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.ijom.2025.09.004_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1600-051x.2002.290106.x","article-title":"Comparative study of Emdogain and coronally advanced flap technique in the treatment of human gingival recessions. A prospective controlled clinical study","volume":"29","author":"H\u00e4gewald","year":"2002","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.ijom.2025.09.004_bib20","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijom.2025.09.004_bib21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bjoms.2016.05.030","article-title":"Influence of zoledronic acid on proliferation, migration, and apoptosis of vascular endothelial cells","volume":"54","author":"Lang","year":"2016","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijom.2025.09.004_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cyto.2014.10.025","article-title":"The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells","volume":"71","author":"Ishtiaq","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.ijom.2025.09.004_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1902\/jop.2007.060111","article-title":"In vitro effects of enamel matrix derivative on microvascular cells","volume":"78","author":"Schlueter","year":"2007","journal-title":"J Periodontol"},{"key":"10.1016\/j.ijom.2025.09.004_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0022034514564187","article-title":"Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition","volume":"94","author":"Nagaoka","year":"2015","journal-title":"J Dent Res"},{"key":"10.1016\/j.ijom.2025.09.004_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ijom.2025.09.004_bib26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ijom.2013.02.008","article-title":"The effects of chronic zoledronate usage on the jaw and long bones evaluated using RANKL and osteoprotegerin levels in an animal model","volume":"42","author":"\u00c7ankaya","year":"2013","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"8 Suppl.","key":"10.1016\/j.ijom.2025.09.004_bib27","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1600-051X.2008.01264.x","article-title":"Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels","volume":"35","author":"Bosshardt","year":"2008","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.ijom.2025.09.004_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jdent.2005.02.006","article-title":"Enamel matrix derivative promotes osteoclast cell formation by RANKL production in mouse marrow cultures","volume":"33","author":"Otsuka","year":"2005","journal-title":"J Dent"},{"key":"10.1016\/j.ijom.2025.09.004_bib29","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","article-title":"IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijom.2025.09.004_bib30","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00784-020-03602-z","article-title":"The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw","volume":"25","author":"Paschalidi","year":"2021","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.ijom.2025.09.004_bib31","first-page":"159","article-title":"Immune-related expression profiles of bisphosphonates-related osteonecrosis of the jaw in multiple myeloma","volume":"76","author":"He","year":"2021","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijom.2025.09.004_bib32","first-page":"177","article-title":"The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and\/or bevacizumab","volume":"28","author":"Papadopoulou","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijom.2025.09.004_bib33","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s00784-016-2033-7","article-title":"Effects of enamel matrix derivative on non-surgical management of peri-implant mucositis: a double-blind randomized clinical trial","volume":"21","author":"Kashefimehr","year":"2017","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.ijom.2025.09.004_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/2041731415575857","article-title":"Subfractions of enamel matrix derivative differentially influence cytokine secretion from human oral fibroblasts","volume":"6","author":"Villa","year":"2015","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.ijom.2025.09.004_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jop.13627","article-title":"Royal jelly as a therapeutic intervention in medication-related osteonecrosis of the jaw (MRONJ): an animal model study","volume":"54","author":"Topan","year":"2025","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijom.2025.09.004_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20128-4","article-title":"Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw","volume":"12","author":"Hadad","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijom.2025.09.004_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jcms.2021.02.018","article-title":"Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis","volume":"49","author":"Schoenhof","year":"2021","journal-title":"J Craniomaxillofac Surg"}],"container-title":["International Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502725014390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0901502725014390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T07:36:48Z","timestamp":1773128208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0901502725014390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0901502725014390"],"URL":"https:\/\/doi.org\/10.1016\/j.ijom.2025.09.004","relation":{},"ISSN":["0901-5027"],"issn-type":[{"value":"0901-5027","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enamel matrix derivative in the prevention and treatment of medication-related osteonecrosis of the jaws in rats","name":"articletitle","label":"Article Title"},{"value":"International Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijom.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}